Is rifabutin prophylaxis against Mycobacterium avium complex infection in HIV infection worthwhile? The net impact on patients suggests not.
AUTOR(ES)
Stephenson, J M
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1195677Documentos Relacionados
- Is rifabutin prophylaxis against Mycobacterium avium complex infection in HIV infection worthwhile?
- Comparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complex.
- Azithromycin, rifabutin, and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporine.
- Is tapping jet nebulisers worthwhile?
- Against the proposition: all patients with advanced HIV disease should be offered rifabutin prophylaxis.